Concepedia

Effects of topical and subconjunctival use of bevacizumab on corneal neovascularization in rabbits’ eyes

Gerson Jorge Aparecido Lopes, Antônio Marcelo Barbante Casella, Ana Paula Miyagusko Taba Oguido, Tiemi Matsuo

Arquivos Brasileiros de Oftalmologia · 2017 · 10 citations · 12 references

DOIFull text

Open access

Abstract

Bevacizumab showed an inhibitory effect on CNV in rabbits' eyes after chemical burning of the cornea. There was no difference between the topical or subconjunctival administration of bevacizumab in the inhibition of CNV.

References

12

Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular DegenerationTwelve-Week Results of an Uncontrolled Open-Label Clinical Study

S. Michels, Philip J. Rosenfeld, C PULIAFITO et al. · Ophthalmology · 2005 · 667 citations · Full text

, , +4

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion.

Philip J. Rosenfeld, Anne E. Fung, Carmen A. Puliafito · PubMed · 2005 · 467 citations

, , +9

Inhibition of Platelet-Derived Growth Factor B Signaling Enhances the Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Multiple Models of Ocular Neovascularization

Nobuo Jo, Carolina Mailhos, Meihua Ju et al. · American Journal Of Pathology · 2006 · 322 citations · Full text

, , +10

VEGF Trap complex formation measures production rates of VEGF, providing a biomarker for predicting efficacious angiogenic blockade

John S. Rudge, Jocelyn Holash, Donna Hylton et al. · Proceedings of the National Academy of Sciences · 2007 · 203 citations · Full text

, , +19

Drug effects on the neovascularization response to silver nitrate cauterization of the rat cornea

Janette M. Mahoney, L. David Waterbury · Current Eye Research · 1985 · 105 citations